James M. Robinson
- 2Articles
- 4.5KReads1
- 2000Active
- 6Collaborators
About
James M. Robinson has published research on the use of a new enteric-coated weekly formulation of fluoxetine in the continuation treatment of major depressive disorder. His work focuses on patient compliance, as well as the efficacy and safety of this medication approach. Robinson's articles appeared in 2000 in Psychiatrist.com, with frequent collaboration alongside Mark E. Schmidt, Ami Claxton, Erik de Klerk, Mark Parry, and Maurizio Fava.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
